GB201608660D0 - Method - Google Patents

Method

Info

Publication number
GB201608660D0
GB201608660D0 GBGB1608660.5A GB201608660A GB201608660D0 GB 201608660 D0 GB201608660 D0 GB 201608660D0 GB 201608660 A GB201608660 A GB 201608660A GB 201608660 D0 GB201608660 D0 GB 201608660D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1608660.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aslan Pharmaceuticals Pte Ltd
Original Assignee
Aslan Pharmaceuticals Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aslan Pharmaceuticals Pte Ltd filed Critical Aslan Pharmaceuticals Pte Ltd
Priority to GBGB1608660.5A priority Critical patent/GB201608660D0/en
Publication of GB201608660D0 publication Critical patent/GB201608660D0/en
Priority to PCT/EP2016/070888 priority patent/WO2017037298A1/en
Priority to CN201680048536.8A priority patent/CN108135900A/en
Priority to EP16774458.0A priority patent/EP3344251B1/en
Priority to KR1020187008556A priority patent/KR20180043356A/en
Priority to KR1020187008555A priority patent/KR20180048804A/en
Priority to US15/757,133 priority patent/US10357494B2/en
Priority to JP2018511204A priority patent/JP2018535923A/en
Priority to CN202110740784.1A priority patent/CN113750238A/en
Priority to ES16774458T priority patent/ES2882031T3/en
Priority to PCT/EP2016/070893 priority patent/WO2017037300A1/en
Priority to ES16774460T priority patent/ES2788162T3/en
Priority to JP2018511226A priority patent/JP7332293B2/en
Priority to CN201680048795.0A priority patent/CN108025010A/en
Priority to US15/757,166 priority patent/US20180353510A1/en
Priority to JP2018511230A priority patent/JP2018526382A/en
Priority to PCT/EP2016/070890 priority patent/WO2017037299A1/en
Priority to EP16774460.6A priority patent/EP3344253B1/en
Priority to EP16774459.8A priority patent/EP3344252B1/en
Priority to PCT/EP2016/070874 priority patent/WO2017037292A1/en
Priority to CN201680049587.2A priority patent/CN108135901A/en
Priority to US15/757,189 priority patent/US10682353B2/en
Priority to US16/134,736 priority patent/US20190117655A1/en
Priority to US16/508,444 priority patent/US10849899B2/en
Ceased legal-status Critical Current

Links

GBGB1608660.5A 2015-09-04 2016-05-17 Method Ceased GB201608660D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GBGB1608660.5A GB201608660D0 (en) 2016-05-17 2016-05-17 Method
US15/757,189 US10682353B2 (en) 2015-09-04 2016-09-05 Varlitinib for use in the treatment of resistant or refractory cancer
PCT/EP2016/070893 WO2017037300A1 (en) 2015-09-04 2016-09-05 Varlitinib for use in the treatment of resistant or refractory cancer
JP2018511226A JP7332293B2 (en) 2015-09-04 2016-09-05 Combination therapy comprising varlitinib and an anticancer agent
EP16774458.0A EP3344251B1 (en) 2015-09-04 2016-09-05 A combination therapy comprising varlitinib and an anticancer agent
KR1020187008556A KR20180043356A (en) 2015-09-04 2016-09-05 Treatment of cholangiocarcinoma
KR1020187008555A KR20180048804A (en) 2015-09-04 2016-09-05 Combination therapy with baritinib and anticancer drugs
US15/757,133 US10357494B2 (en) 2015-09-04 2016-09-05 Combination therapy comprising varlitinib and an anticancer agent
JP2018511204A JP2018535923A (en) 2015-09-04 2016-09-05 Treatment of biliary tract cancer
CN202110740784.1A CN113750238A (en) 2015-09-04 2016-09-05 Combination therapy comprising varlitinib and an anti-cancer agent
ES16774458T ES2882031T3 (en) 2015-09-04 2016-09-05 A combination therapy comprising varlitinib and an antineoplastic agent
PCT/EP2016/070888 WO2017037298A1 (en) 2015-09-04 2016-09-05 A combination therapy comprising varlitinib and an anticancer agent
ES16774460T ES2788162T3 (en) 2015-09-04 2016-09-05 Varlitinib for use in the treatment of resistant or refractory cancer
CN201680048536.8A CN108135900A (en) 2015-09-04 2016-09-05 Comprising Giovanni for Buddhist nun and the combination treatment of anticancer agent
CN201680048795.0A CN108025010A (en) 2015-09-04 2016-09-05 Giovanni for treating drug resistance or intractable cancer replaces Buddhist nun
US15/757,166 US20180353510A1 (en) 2015-09-04 2016-09-05 Treatment of Biliary Duct Cancer
JP2018511230A JP2018526382A (en) 2015-09-04 2016-09-05 Valritinib for the treatment of resistant or refractory cancer
PCT/EP2016/070890 WO2017037299A1 (en) 2015-09-04 2016-09-05 Treatment of biliary duct cancer
EP16774460.6A EP3344253B1 (en) 2015-09-04 2016-09-05 Varlitinib for use in the treatment of resistant or refractory cancer
EP16774459.8A EP3344252B1 (en) 2015-09-04 2016-09-05 Treatment of biliary duct cancer
PCT/EP2016/070874 WO2017037292A1 (en) 2015-09-04 2016-09-05 Combination of a dhodh inhibitor and a her inhibitor for use in the treatment of cancer
CN201680049587.2A CN108135901A (en) 2015-09-04 2016-09-05 the treatment of cholangiocarcinoma
US16/134,736 US20190117655A1 (en) 2015-09-04 2018-09-18 Treatment of Biliary Duct Cancer
US16/508,444 US10849899B2 (en) 2015-09-04 2019-07-11 Combination therapy comprising Varlitinib and an anticancer agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1608660.5A GB201608660D0 (en) 2016-05-17 2016-05-17 Method

Publications (1)

Publication Number Publication Date
GB201608660D0 true GB201608660D0 (en) 2016-06-29

Family

ID=56320538

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1608660.5A Ceased GB201608660D0 (en) 2015-09-04 2016-05-17 Method

Country Status (1)

Country Link
GB (1) GB201608660D0 (en)

Similar Documents

Publication Publication Date Title
GB201607521D0 (en) Method
GB201609221D0 (en) Method
GB201609220D0 (en) Method
GB201602394D0 (en) Method
GB201601773D0 (en) Method
GB201608918D0 (en) Method
GB201603367D0 (en) Method
GB201608403D0 (en) Method
GB201614884D0 (en) Method
GB201607572D0 (en) Alyklation method
GB201602927D0 (en) Method
GB201601120D0 (en) Eye-testing method
GB201608969D0 (en) Method
GB201608806D0 (en) Method
GB201608848D0 (en) Method
GB201608658D0 (en) Method
GB201608660D0 (en) Method
GB201608469D0 (en) Method
GB201607828D0 (en) Method
GB201607463D0 (en) Method
GB201604898D0 (en) Method
GB201604620D0 (en) Method
GB201604572D0 (en) Method
GB201604291D0 (en) Method
GB201604204D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)